Vanderbilt Health to Lead AI and Genomics Research Consortium

Vanderbilt Health will lead a new research consortium with a total budget of $12.8 million, aiming to translate genomics research into clinical applications using artificial intelligence and machine learning tools.

Establishment of the MAGen Consortium

Established by the National Institutes of Health, the consortium named MAGen is supported by total grants of $12.8 million over five years. This initiative leverages artificial intelligence and machine learning technologies to ensure the transition of genomic research into clinical fields.

Leadership of the Coordination Center

Bradley Malin is leading the consortium coordination center to be established within Vanderbilt. Under the five-year phased innovation award, Malin receives a $1.2 million grant for the first two years, while this figure is projected to be $3.6 million for the subsequent years.

Development Centers and Project Partners

Other development centers of the consortium are located within Massachusetts General Hospital and the Icahn School of Medicine at Mount Sinai. Meanwhile, the development site at Vanderbilt is managed by Lisa Bastarache and receives a $3.2 million grant for the first two years.

GenePath and Expert Team

The coordination center, named GenePath, brings together experts in areas such as variant interpretation, protein function, and health equity. In the project, Bradley Malin is accompanied by co-principal investigators such as Jada Benn Torres and Wei-Qi Wei.